Search Results 21-30 of 16392 for CLL

  1. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls - Mayo Clinic

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls · Overview.

  2. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

  3. Acute lymphocytic leukemia - Symptoms and causes - Mayo Clinic

    Learn about this cancer that forms in the blood and bone marrow. Treatments include medications and bone marrow transplant.

  4. Overview - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic studies the genetic epidemiology of chronic lymphocytic leukemia (CLL), monoclonal B-cell ...

  5. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    - Diagnosis of chronic lymphocytic leukemia (CLL) with a clonal B-cell population in the peripheral blood with immunophenotyping consistent with CLL as follows:

  6. Epidemiology of Monoclonal B-Cell Lymphocytosis Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Family history. People with a family history of chronic lymphocytic leukemia are about eight times more likely to develop CLL than are people without a family ...

  7. A Study of CG-806 in Patients with Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas for which either the standard treatment has failed, is no ...

  8. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    ... chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  9. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Giving ibrutinib and obinutuzumab with venetoclax may work better at treating chronic lymphocytic leukemia. Participation eligibility. Participant eligibility ...

  10. Global Trial in APG2575 for Patients With CLL/​SLL - Mayo Clinic

    About this study. The purpose of this study is to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients ...